Skip to main content

Peer Review reports

From: Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report

Original Submission
3 May 2019 Submitted Original manuscript
13 May 2019 Reviewed Reviewer Report - Huseyin Eken
16 May 2019 Reviewed Reviewer Report - stefania erra
22 May 2019 Author responded Author comments - Morgane Broudic-Guibert
Resubmission - Version 2
22 May 2019 Submitted Manuscript version 2
27 May 2019 Author responded Author comments - Morgane Broudic-Guibert
Resubmission - Version 3
27 May 2019 Submitted Manuscript version 3
Publishing
30 May 2019 Editorially accepted
25 Jul 2019 Article published 10.1186/s13256-019-2140-6

You can find further information about peer review here.

Back to article page